Stokes Family Office’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Stokes Family Office's CL Position: Q2 2026 in Review
Stokes Family Office reduced its Colgate-Palmolive (CL) stake by 5.1% in Q2 2026, selling an estimated $10.8K and leaving 2,305 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #262.
Stokes Family Office first reported a position in CL in Q3 2020 and has held it in 16 quarters since. The position peaked at $459K in Q4 2020. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Stokes Family Office held 2,305 shares of Colgate-Palmolive worth $211K as of Q2 2026.
- Stokes Family Office sold 123 Colgate-Palmolive shares in Q2 2026, an estimated $10.8K.
- Colgate-Palmolive made up 0.02% of Stokes Family Office's portfolio in Q2 2026, its #262 holding.
- Stokes Family Office first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 16 quarters since.
- Stokes Family Office's Colgate-Palmolive position peaked at $459K in Q4 2020.
- 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.